Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue        
Revenue
Other revenue 45 233 1,030 1,121
Total revenue 45 233 1,030 1,121
Operating expenses:        
Research and development, net of reimbursements 6,771 4,708 15,802 12,615
General and administrative 3,073 1,994 8,041 5,422
Total operating expenses 9,844 6,702 23,843 18,037
Loss from operations (9,799) (6,469) (22,813) (16,916)
Other income:        
Interest income - net 325 46 443 152
Total other income 325 46 443 152
Net loss $ (9,474) $ (6,423) $ (22,370) $ (16,764)
Net loss per common share – basic and diluted (in Dollars per share) $ (0.38) $ (0.3) $ (0.94) $ (0.84)
Weighted average common shares outstanding – basic and diluted (in Shares) 25,164,599 21,539,455 23,691,218 20,060,315